BIOMARKER:

EGFR C797S

C2 | Sensitive

C3 | Sensitive

C4 | Sensitive

D | Sensitive

C2 | Resistant

C3 | Resistant

C4 | Resistant

D | Resistant

Non Small Cell Lung Cancer

Lung Adenocarcinoma

Lung Cancer

amivantamab-vmjw

EGFR C797S|Non Small Cell Lung Cancer|amivantamab-vmjw

JIN-A02

EGFR C797S|Non Small Cell Lung Cancer|JIN-A02

U3-1402

EGFR C797S|Non Small Cell Lung Cancer|U3-1402

cetuximab + brigatinib

EGFR C797S|Non Small Cell Lung Cancer|cetuximab + brigatinib

brigatinib

EGFR C797S|Lung Adenocarcinoma|brigatinib

bevacizumab + afatinib

EGFR C797S|Non Small Cell Lung Cancer|bevacizumab + afatinib

BBT-176

EGFR C797S|Non Small Cell Lung Cancer|BBT-176

rociletinib

EGFR C797S|Non Small Cell Lung Cancer|rociletinib

OBX02-011

EGFR C797S|Non Small Cell Lung Cancer|OBX02-011

BLU-945 + BLU-701

EGFR C797S|Non Small Cell Lung Cancer|BLU-945 + BLU-701

GB263T

EGFR C797S|Non Small Cell Lung Cancer|GB263T

TRX-221

EGFR C797S|Non Small Cell Lung Cancer|TRX-221

APG-1252

EGFR C797S|Non Small Cell Lung Cancer|APG-1252

afatinib

EGFR C797S|Lung Cancer|afatinib

erlotinib

EGFR C797S|Lung Cancer|erlotinib

olmutinib

EGFR C797S|Non Small Cell Lung Cancer|olmutinib

WZ4002

EGFR C797S|Non Small Cell Lung Cancer|WZ4002

Immunotherapy

EGFR C797S|Non Small Cell Lung Cancer|Immunotherapy

osimertinib

EGFR C797S|Non Small Cell Lung Cancer|osimertinib

EGFR C797S|Lung Adenocarcinoma|osimertinib

EGFR inhibitor

EGFR C797S|Lung Cancer|EGFR inhibitor

Notch inhibitor + osimertinib

EGFR C797S|Lung Adenocarcinoma|Notch inhibitor + osimertinib